| Literature DB >> 26159119 |
Kazuhiko Sakamoto1, Takao Tamesa2, Tokumitu Yukio2, Yoshihiro Tokuhisa2, Yoshinari Maeda2, Masaaki Oka2.
Abstract
BACKGROUND: The purpose of this study was to retrospectively determine the risk factors and evaluate the management of bile leakage.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26159119 PMCID: PMC4695499 DOI: 10.1007/s00268-015-3156-8
Source DB: PubMed Journal: World J Surg ISSN: 0364-2313 Impact factor: 3.352
Characteristics of patients with and without bile leakage
| Total population ( | Bile leakage (−) ( | Bile leakage (+) ( |
| |
|---|---|---|---|---|
| Age | 68 (32–87) | 68 (32–87) | 70 (39–81) | 0.83 |
| Gender | ||||
| Male | 242 | 220 (91.3 %) | 22 (8.7 %) | 0.91 |
| Female | 92 | 84 (90.9 %) | 8 (9.1 %) | |
| Disease | ||||
| HCC | 245 | 222 (90.6 %) | 23 (9.4 %) | 0.52 |
| Metastatic tumor | 59 | 53 (89.8 %) | 6 (10.2 %) | |
| Others | 30 | 29 (96.7 %) | 1 (3.3 %) | |
| Fibrosis staging | ||||
| F 0–2 | 185 | 167 (90.3 %) | 18 (9.7 %) | 0.59 |
| F 3–4 | 149 | 137 (91.9 %) | 12 (8.1 %) | |
| Glucose intolerance | ||||
| No | 239 | 217 (90.8 %) | 22 (9.2 %) | 0.82 |
| Yes | 95 | 87 (91.6 %) | 8 (8.4 %) | |
| Previous hepatectomy | ||||
| No | 296 | 272 (91.9 %) | 24 (8.1 %) | 0.11 |
| Yes | 38 | 32 (84.2 %) | 6 (15.8 %) | |
| Preoperative TACE, RFA or PEI | ||||
| No | 266 | 242 (91.0 %) | 24 (9.0 %) | 0.96 |
| Yes | 68 | 62 (91.2 %) | 6 (8.8 %) | |
| Period | ||||
| 2003–2006 | 128 | 120 (93.8 %) | 8 (6.3 %) | 0.17 |
| 2007–2013 | 206 | 184 (89.3 %) | 22 (10.7 %) | |
| Operation time (min) | 350 (76–1028) | 343 (76–1015) | 444 (266–1028) | <0.01* |
| Blood loss (g) | 498 (13–9425) | 470 (13–4944) | 740 (145–9425) | 0.049* |
| Use of C tube | ||||
| No | 177 | 165 (93.2 %) | 12 (6.8 %) | 0.14 |
| Yes | 157 | 139 (88.5 %) | 18 (11.5 %) | |
| Mortality | ||||
| No | 331 | 302 (91.2 %) | 29 (8.8 %) | 0.25 |
| Yes | 3 | 2 (66.7 %) | 1 (33.3 %) | |
Data are presented as absolute numbers (percentage) or median (range minimum–maximum)
HCC hepatocellular carcinoma, TACE transcatheter arterial chemoembolization, RFA radiofrequency ablation PEI percutaneous ethanol injection
* p < 0.05
Type of hepatectomy in patients with and without bile leakage
| Bile leakage (−) ( | Bile leakage (+) ( | p value | ||
|---|---|---|---|---|
| Central type ( | Peripheral type ( | |||
| Type of hepatectomy | 0.015 | |||
| Partial hepatectomy | 149 (95.5 %) | 7 (4.5 %) | ||
| Segmentectomy 2, 3, 5, 6, 7, or 8 | 5 | 2 | ||
| Left hepatectomy (extended) | 37 (88.1 %) | 5 (11.9 %) | ||
| 5 | 0 | |||
| Posterior sectionectomy | 68 (90.7 %) | 7 (9.3 %) | ||
| Right hepatectomy (extended) | 3 | 4 | ||
| Segmentectomy 1 | 50 (82.0 %) | 11 (18.0 %) | ||
| Medial sectionectomy | 10 | 1 | ||
| Anterior sectionectomy | ||||
| Central bisectionectomy | ||||
Data are presented as absolute numbers
Fig. 1Receiver operating characteristic curve analysis for operating time and blood loss
Factors predicting the development of bile leakage on multivariate logistic regression analysis
| Factor | OR | 95 % CI |
|
|---|---|---|---|
| Type of hepatectomy | |||
| Segmentectomy 1, medial sectionectomy, anterior sectionectomy, or central bisectionectomy | 2.3 | 1.0–5.3 | 0.049* |
| Operation time (min) (≥384 vs. <384) | 4.2 | 1.6–10.6 | 0.003* |
| Blood loss (g) (≥628 vs. <628) | 1.4 | 0.58–3.3 | 0.47 |
OR odds ratios, CI confidence interval
* p < 0.05
Characteristics of bile leakage
| Bile leakage ( | ||
|---|---|---|
| Central type ( | Peripheral type ( | |
| Median duration from operation to diagnosis of bile leakage (days)a | 7 (1–70) | 6 (3–24) |
| Diagnosis | ||
| Gross finding | 4 | 0 |
| Drain/serum total bilirubin ratio ≥ 3.0 | 3 | 6 |
| Drain exchange | 7 | 0 |
| Percutaneous drainage | 9 | 1 |
| Median duration from diagnosis to end of therapy (days)a | 77 (11–323) | 44 (6–123) |
| Treatmentb | ||
| Only drainage | 8 (1)c | 2 |
| Endoscopic or | 15 (1)c | 0 |
| Percutaneous transhepatic procedure | ||
| Portal vein embolization | 1 | 0 |
| Hepatectomy | 1 | 0 |
| Fistulojejunostomy | 1 | 0 |
| Ablation treatment | 2 | 5 |
aData are presented as median (range minimum–maximum)
bThere are duplicated cases
cTwo patients with central type leakage died during treatment
Fig. 2Among patients with central type bile leakage, seven of them were successfully treated by only drainage (one patient died during drainage). After drainage, endoscopic or percutaneous transhepatic procedures were performed in 15 patients, 12 of whom were cured (one patient died during treatment). In two patients who were difficult to cure by this treatment, ablation treatment, portal vein embolization, or fistulojejunostomy were performed. Two patients with peripheral type bile leakage were cured by drainage alone. After drainage, ethanol or minocycline ablation was performed in five patients, the procedure being successful in all of them. “Cure” is defined as the time until drainage tube is completely removed